Clinical Trials Logo

Clinical Trial Details — Status: Approved for marketing

Administrative data

NCT number NCT01579890
Other study ID # 105-95
Secondary ID
Status Approved for marketing
Phase N/A
First received April 16, 2012
Last updated April 17, 2012

Study information

Verified date April 2012
Source Mallinckrodt
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Expanded Access

Clinical Trial Summary

This was a compassionate use, open treatment safety study of Pennsaid topical lotion (diclofenac) for osteo or rheumatoid arthritis.


Recruitment information / eligibility

Status Approved for marketing
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- diagnosed osteo or rheumatoid arthritis

- Oral NSAIDs were not deemed appropriate treatment

- Completed diclofenac sensitivity patch test with negative result

- Signed informed consent form

Exclusion Criteria:

- At the discretion of the physician and HPB

Study Design

N/A


Intervention

Drug:
Diclofenac
diclofenac topical lotion

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Mallinckrodt Nuvo Research Inc.
See also
  Status Clinical Trial Phase
Completed NCT02762760 - AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint Phase 1